Company Description
Seattle Genetics is working on monoclonal antibodies (MAbs) to treat a variety of cancers and autoimmune diseases. It is developing MAbs potent...
Key Seattle Genetics Financials
| Company Type | Public - NASDAQ (GM): SGEN Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $22.4 |
| 2005 Employees | 140 |
More Seattle Genetics Financials (11 pages)
Latest Seattle Genetics Jobs jobs by Indeed
Competition
Competitive Landscape for Chemicals
Demand is driven by the health of the US economy because chemicals are used to make a wide variety of industrial and consumer products. The profitability of individual companies is closely tied to...
Read more about Seattle Genetics's competition across multiple industries
Top Seattle Genetics Competitors
Sponsored Links
The Business Directory
Seattle Genetics Executives
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman, President, and CEO | Clay B. Siegall | Network | E-mail |
| CFO | Todd E. Simpson | Network | E-mail |
| Chief Business Officer | Eric L. Dobmeier | Network | E-mail |
More Seattle Genetics Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Seattle Genetics News
- Seattle Genetics Inc. (SGEN) Corporate Event Announcement Notice [Wall Street Horizon] (09 Oct 2008 21:39:00 EDT)
- METHODS AND COMPOSITIONS FOR TREATING DISEASES TARGETING HUMAN PROMININ-1(CD133) [PCT Biblio Info] (09 Oct 2008 11:39:00 EDT)
- Seattle Genetics Inc. (SGEN) Corporate Event Announcement Notice [Wall Street Horizon] (08 Oct 2008 21:31:00 EDT)
Sponsored Opportunity
